

AutoPiX is a major international project focused on improving healthcare for people with rheumatic and musculoskeletal diseases (RMDs).
The AutoPiX project brings together pharmaceutical and medical technology partners with leading academic institutions to enhance the use of imaging biomarkers for patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA), collectively known as systemic arthritides.
It aims to develop advanced imaging tools and artificial intelligence (AI) models to better diagnose, monitor, and treat these conditions. These tools will make use of imaging biomarkers—like X-rays, ultrasounds, and MRIs—to provide more precise and personalised care.
The Innovative Health Initiative from the EU Commission (IHI) is a partnership for health research and innovation between the EU and Europe's life science industries.
IHI has a total budget of €2.4 billion and is expected to have impacts on the research and innovation ecosystem; on patients and health systems; and on Europe’s competitiveness.
The Strategic Research and Innovation Agenda (SRIA) details the areas IHI should work on and helps to guide IHI’s decisions on which ideas should be turned into call topics.